Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL)

Bioconjugate Chemistry

Volumn 20, Issue 6, 2009, Pages 1201-1208

  Beuttler, Julia ^a   Rothdiener, Miriam ^a   Müller, Dafne ^a   Frejd, Fredrik Y ^b,c   Kontermann, Roland E ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b Affibody AB   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; LIPOSOME; MACROGOL 2000; MALEIMIDE DERIVATIVE; MITOXANTRONE; STABILIZED AFFIBODY LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 67649240316     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900061v     Document Type: Article

References (39)

1. Mendeson, J., and Baselga, J. (2006) Epidermal growth factor receptor targeting in cancer. Semin. Oncol. 33, 369-385. (Pubitemid 44142736)
2. Nicholson, R. I., Gee, J. M. W., and Harper, M. E. (2001) EGFR and cancer prognosis. Eur. J. Cancer 37, S9-S15. (Pubitemid 32938124)
3. Mamot, C., and Rochlitz, C. (2006) Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology? Swiss Med. Wkly. 136, 4-12. (Pubitemid 43151760)
4. Rocha-Lima, C. M., Soares, H. P., Raez, L. E., and Singal, R. (2007) EGFR targeting of solid tumors. Cancer Control 14, 295-304. (Pubitemid 47057800)
5. Samad, A., Sultana, Y., and Aqil, M. (2007) Liposomal drug delivery systems: an update review. Curr. Drug Delivery 4, 297-305. (Pubitemid 47554274)
6. Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., and Papahadjopoulos, D. (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51, 691-743.
7. Park, J. W., Benz, C. C., and Martin, F. J. (2004) Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin. Oncol. 31 (1), 196-205. (Pubitemid 40023249)
8. Sapra, P., Tyagi, P., and Allen, T. A. (2005) Ligand-targeted liposomes for cancer treatment. Curr. Drug Delivery 2, 369-381. (Pubitemid 41277769)
9. Sofou, S., and Sgouros, G. (2008) Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin. Drug Delivery 5, 189-204. (Pubitemid 351308311)
10. Kontermann, R. E. (2006) Immunoliposomes for cancer therapy. Curr. Opin. Mol. Ther. 8, 39-45. (Pubitemid 43230899)
11. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W. (2003) Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63, 3154-3161. (Pubitemid 36735867)
12. Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., and Park, J. W. (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res. 65, 11631-11638. (Pubitemid 41821723)
13. Mamot, C., Ritschard, R., Küng, W., Park, J. W., Herrmann, R., and Rochlitz, C. F. (2006) EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. J. Drug Targeting 14, 215-223. (Pubitemid 43922062)
14. Holliger, P., and Hudson, P. J. (2005) Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136. (Pubitemid 41486394)
15. Tolmachev, V., Orlova, A., Nilsson, F. Y., Feldwisch, J., Wennborg, A., and Abrahmsén, L. (2007) Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy. Exp. Opin. Biol. Ther. 7 555-568. (Pubitemid 46524679)
16. Nilsson, F. Y., and Tolmachev, V. (2007) Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy. Curr. Opin. Drug Discovery Dev. 10, 167-175. (Pubitemid 46438646)
17. Nygren, P. Å. (2008) Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold. FEBS J. 275, 2668-2676. (Pubitemid 351678678)
18. Friedman, M., Nordberg, E., Hoidén-Guthenberg, I., Brismar, H., Adams, G. P., Nilsson, F. Y., Carlsson, J., and Ståhl, S. (2007) Phage display selection of affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. Protein Eng. Des. Sel. 20, 189-199. (Pubitemid 351321300)
19. Friedman, M., Orlova, A., Johansson, E., Eriksson, T. L. J., Höidén-Guthenberg, I., Tolmachev, V., Nilsson, F. Y., and Ståhl, S. (2008) Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor 1-binding affibody molecule. J. Mol. Biol. 376, 1388-1402.
20. Nordberg, E., Friedman, M., Göstring, L., Adams, G. P., Brismar, H., Nilsson, F. Y., Ståhl, S., Glimelius, B., and Carlsson, J. (2007) Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl. Med. Biol. 34, 609-618. (Pubitemid 47248288)
21. Tolmachev, V., Friedman, M., Sandström, M., Eriksson, T. L. J., Rosik, D., Hodik, M., Ståhl, S., Frejd, F. Y., and Orlova, A. (2009) Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J. Nucl. Med. 50, 274-283.
22. Messerschmidt, S. K. E., Kolbe, A., Müller, D., Knoll, M., Pleiss, J., and Kontermann, R. E. (2008) Novel single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling. Bioconjugate Chem. 19, 362-369. (Pubitemid 351213871)
23. Lim, H. J., Masin, D., Mctintosh, N. L., Madden, T. D., and Bally, M. B. (2000) Role of drug release and liposome-mediated drug delivery in govering the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. J. Pharmacol. Exp. Ther. 292, 337-345. (Pubitemid 30026391)
24. Bach, M., Hölig, P., Schlosser, E., Völkel, T., Graser, A., Müller, R., and Kontermann, R. E. (2003) Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional coupling as targeting ligands. Protein Eng. 16, 1107-1113. (Pubitemid 38281762)
25. Lee, R. J., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204. (Pubitemid 24237629)
26. Alexis, F., Basto, P., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Zhang, L., Pridgen, E., Wang, A. Z., Marein, S. L., Westerhof, L., Molnar, L. K., and Farokhzad, O. C. (2008) HER-2-targeted nanoparticle-affibody conjugates for cancer therapy. ChemMedChem 3, 1839-1843.
27. Puri, A., Kramer-Marek, G., Campbell-Massa, R., Yavlovich, A., Tele, S. C., Lee, S.-B., Clogston, J. D., Patri, A. K., Blumenthal, R., and Capala, J. (2008) HER-2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents. J. Liposome Res. 18, 293-307.
28. Orlova, A., Feldwisch, J., Abrahmsén, L., and Tolmachev, V. (2007) Update: affibody molecules for molecular imaging and therapy for cancer. Cancer Biother. Radiopharm. 22, 573-584. (Pubitemid 350058993)
29. Arora, P., Oas, T. G., and Myers, J. K. (2004) Fast and faster: a desgined variant of the B-domain of protein A folds in 3 μsec. Protein Sci. 13, 847-853. (Pubitemid 38429208)
30. Orlova, A., Magnusson, M., Eriksson, T. L., Nilsson, M., Larsson, B., Hoidén-Guthenberg, I., Widstörm, C., Carlsson, J., Tolmachev, V., Stahl, S., and Nilsson, F. Y. (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 66, 4339-4348.
31. Simões, S., Moreira, J. N., Fonseca, C., Düzgunes, N., and Pedroso de Lima, M. (2004) On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Delivery Rev. 56, 947-965.
32. Ishida, T., Okada, Y., Kobayashi, T., and Kiwada, H. (2006) Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood. Int. J. Pharmaceut. 309, 94-100. (Pubitemid 43129470)
33. Kawano, K., Onose, E., Hattori, Y., and Maitani, Y. (2008) Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol. Pharm. 6, 98-104.
34. Sapra, P., and Allen, T. M. (2003) Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42, 439-462. (Pubitemid 36700404)
35. Sapra, P., Moase, E. H., Ma, J., and Allen, T. M. (2004) Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab′ fragments. Clin. Cancer Res. 10, 1100-1111. (Pubitemid 38198912)
36. Nielson, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Shalaby, M. R., Shao, Y., Benz, C. C., and Marks, J. D. (2002) Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis. Biochim. Biphys. Acta 1591, 109-118. (Pubitemid 35232074)
37. Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielson, U. B., Marks, J. D., Papahadopoulos, D., and Benz, C. C. (2001) Tumor targeting using anti-her2 immunoliposomes. J. Controlled Release 74, 95-113. (Pubitemid 32727613)
38. Drummond, D. C., Shao, Y., Shalaby, M. R., Nielson, U. B., Marks, J. D., Benz, C. C., and Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66, 6732-6740. (Pubitemid 44085631)
39. Shmeeda, H., Tzemach, D., Mak, L., and Gabizon, A. (2009) Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. J. Controlled Release [Online early access] DOI: 10.1016/j.jconrel.2009.02.002.